Pharmacokinetics of sepantronium bromide (YM155), a small-molecule suppressor of survivin, in Japanese patients with advanced solid tumors: dose proportionality and influence of renal impairment.
about
Response of Merkel cell polyomavirus-positive merkel cell carcinoma xenografts to a survivin inhibitor.Manipulating the apoptotic pathway: potential therapeutics for cancer patients.Small Molecule Survivin Inhibitor YM155 Displays Potent Activity Against Human Osteosarcoma Cells.YM155 sensitizes triple-negative breast cancer to membrane-bound TRAIL through p38 MAPK- and CHOP-mediated DR5 upregulation.
P2860
Pharmacokinetics of sepantronium bromide (YM155), a small-molecule suppressor of survivin, in Japanese patients with advanced solid tumors: dose proportionality and influence of renal impairment.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Pharmacokinetics of sepantroni ...... influence of renal impairment.
@ast
Pharmacokinetics of sepantroni ...... influence of renal impairment.
@en
type
label
Pharmacokinetics of sepantroni ...... influence of renal impairment.
@ast
Pharmacokinetics of sepantroni ...... influence of renal impairment.
@en
prefLabel
Pharmacokinetics of sepantroni ...... influence of renal impairment.
@ast
Pharmacokinetics of sepantroni ...... influence of renal impairment.
@en
P2093
P2860
P1476
Pharmacokinetics of sepantroni ...... influence of renal impairment.
@en
P2093
Kazuhiko Nakagawa
Masataka Katashima
Taiji Sawamoto
Taroh Satoh
Tetsuya Nishimura
Yumiko Aoyama
P2860
P2888
P304
P356
10.1007/S00280-012-1913-Z
P577
2012-07-18T00:00:00Z